This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Almus-Jacobs, F. Articles by Loskutoff, D. J. Search for Related Content PubMed PubMed Citation Articles by Almus-Jacobs, F. Articles by Loskutoff, D. J.

American Journal of Pathology, Vol 147, 688-698, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Endotoxin stimulates expression of the murine urokinase receptor gene in vivo

F Almus-Jacobs, N Varki, MS Sawdey and DJ Loskutoff
Department of Vascular Biology, Scripps Research Institute, La Jolla, California 92037, USA.

The regulation of urokinase receptor (u-PAR) gene expression during endotoxemia was studied in vivo with a murine model system. Northern blot analysis demonstrated relatively high levels of u-PAR mRNA in mouse placenta, with intermediate levels in lung and spleen and very low levels in heart and kidney. No u-PAR mRNA could be detected in liver, gut, thymus, brain, or skeletal muscle. Intraperitoneal injection of endotoxin (lipopolysaccharide) increased the steady-state levels of u-PAR mRNA in most tissues examined. The greatest induction (sevenfold) was observed in the lung at 1 hour after injection. The cellular localization of u-PAR mRNA was assessed by in situ hybridization. In control mice, u-PAR mRNA was detected primarily in alveolar macrophages of the lung and lymphocytes of the spleen and thymus, although a specific signal was also present in other cell types. In general, endothelial cells lacked detectable u-PAR mRNA. The induction of u-PAR mRNA by lipopolysaccharide was apparent within 30 minutes and was localized to tissue macrophages, lymphocytes, and endothelial cells lining arteries and veins. At later times (1 to 3 hours), specialized epithelial cells present in gastrointestinal tract, bile ducts, and uterus were also positive for u-PAR mRNA. Induction of u-PAR in vivo by lipopolysaccharide may facilitate the extravasation and migration of leukocytes during inflammation.

This article has been cited by other articles:

				A. A. Eddy and A. B. Fogo Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2999 - 3012. [Full Text] [PDF]

				W. Xiao, Y.-P. Hsu, A. Ishizaka, T. Kirikae, and R. B. Moss Sputum Cathelicidin, Urokinase Plasminogen Activation System Components, and Cytokines Discriminate Cystic Fibrosis, COPD, and Asthma Inflammation Chest, October 1, 2005; 128(4): 2316 - 2326. [Abstract] [Full Text] [PDF]

				H. Wang, L. Yang, Md. S. Jamaluddin, and D. D. Boyd The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells J. Biol. Chem., May 21, 2004; 279(21): 22674 - 22683. [Abstract] [Full Text] [PDF]

				H. Wang, J. Hicks, P. Khanbolooki, S.-J. Kim, C. Yan, Y. Wang, and D. Boyd Transgenic Mice Demonstrate Novel Promoter Regions for Tissue-Specific Expression of the Urokinase Receptor Gene Am. J. Pathol., August 1, 2003; 163(2): 453 - 464. [Abstract] [Full Text] [PDF]

				G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, P. Carmeliet, and A. A. Eddy Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1234 - 1253. [Abstract] [Full Text] [PDF]

				G. Zhang, H. Kim, X. Cai, J. M. Lopez-Guisa, C. E. Alpers, Y. Liu, P. Carmeliet, and A. A. Eddy Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1254 - 1271. [Abstract] [Full Text] [PDF]

				N. P. Juffermans, P. E. P. Dekkers, A. Verbon, P. Speelman, S. J. H. van Deventer, and T. van der Poll Concurrent Upregulation of Urokinase Plasminogen Activator Receptor and CD11b during Tuberculosis and Experimental Endotoxemia Infect. Immun., August 1, 2001; 69(8): 5182 - 5185. [Abstract] [Full Text] [PDF]

				H. Solberg, M. Ploug, G. Høyer–Hansen, B. S. Nielsen, and L. R. Lund The Murine Receptor for Urokinase-Type Plasminogen Activator Is Primarily Expressed in Tissues Actively Undergoing Remodeling J. Histochem. Cytochem., February 1, 2001; 49(2): 237 - 246. [Abstract] [Full Text]

				J. L. Coleman, J. A. Gebbia, and J. L. Benach Borrelia burgdorferi and Other Bacterial Products Induce Expression and Release of the Urokinase Receptor (CD87) J. Immunol., January 1, 2001; 166(1): 473 - 480. [Abstract] [Full Text] [PDF]

				P. E. P. Dekkers, T. ten Hove, A. A. te Velde, S. J. H. van Deventer, and T. van der Poll Upregulation of Monocyte Urokinase Plasminogen Activator Receptor during Human Endotoxemia Infect. Immun., April 1, 2000; 68(4): 2156 - 2160. [Abstract] [Full Text] [PDF]

				S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, S R Kim, H Itoh, et al. Urokinase type plasminogen activator receptor expression in colorectal neoplasms Gut, December 1, 1998; 43(6): 798 - 805. [Abstract] [Full Text] [PDF]

				A. R. Kitching, S. R. Holdsworth, V. A. Ploplis, E. F. Plow, D. Collen, P. Carmeliet, and P. G. Tipping Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis J. Exp. Med., March 3, 1997; 185(5): 963 - 968. [Abstract] [Full Text] [PDF]